INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
112 hedge funds and large institutions have $170M invested in Insys Therapeutics, Inc. in 2017 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 35 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
37% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 35
Holders
112
Holding in Top 10
–
Calls
$4.87M
Puts
$3.65M
Top Buyers
| 1 | +$4.21M | |
| 2 | +$3.25M | |
| 3 | +$2.36M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.15M |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$1M |
Top Sellers
| 1 | -$7.36M | |
| 2 | -$6.57M | |
| 3 | -$3.52M | |
| 4 |
SCM
Schneider Capital Management
Berwyn,
Pennsylvania
|
-$1.61M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.55M |